Study of the Effect of VX-770 on Hyperpolarized Helium-3 Magnetic Resonance Imaging in Subjects With Cystic Fibrosis and the G551D Mutation
Clinical trial NCT01161537 · COMPLETED
Trial details
- NCT number
- NCT01161537
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2013-02-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.